Role of Cell-matrix Interactions in Osteoclast Differentiation
Osteoclast and their mononuclear cell precursors are present within the bone microenvironment at sites of physiologic and pathologic bone resorption. Analysis of tissues from sites of bone resorption reveal that cells expressing the full morphological and functional properties of mature osteoclasts are restricted to the immediate bone surface. We hypothesize that in addition to cytokines, components of the bone matrix and specific cell surface receptors on osteoclasts and their precursors play an essential role in determining the genetic profile and functional properties of fully differentiated resorbing osteoclasts. We have employed expression profiling, with an in vitro model of matrix-dependent osteoclast differentiation, to identify the molecular pathways by which bone matrix-interactions induce terminal osteoclast differentiation and activation. In preliminary studies, we have identified unique genes and transcriptional pathways that are induced by interaction of osteoclast precursors with specific components of the mineralized bone matrix. The authenticity of the gene profiles, as markers of osteoclast differentiation and activation, have been provisionally validated using an in vivo animal bone implantation model and by examination of tissues from patients with specific forms of pathologic osteoclast-mediated bone resorption. The ultimate goal of our studies is to identify new molecular targets for inhibiting osteoclast-mediated bone loss in disorders of pathologic bone loss.
KeywordsBone Resorption Osteoclast Differentiation Tartrate Resistant Acid Phosphatase Osteoclast Precursor Calcitonin Receptor
Unable to display preview. Download preview PDF.
- Athanasou, N.A. 1996. Cellular biology of bone-resorbing cells. J Bone J Surg 78-A: 87–102.Google Scholar
- Karsdal, M.A., M.S. Fjording, N.T. Foged, J.M. Delaisse, and A. Lochter. 2001. Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway. J Biol Chem 276: 39350–39358.CrossRefPubMedGoogle Scholar
- McHugh, K.P., Z. Shen, J. Fleming, T.N. Crotti, Y. Harada, B.E. Bierbaum, and S.R. Goldring. 2005. Bone substrate-specific induction of the CTR gene in peri-implant osteolysis: ORS Transactions, Vol. 30. Washington, DC, p. 147.Google Scholar
- McHugh, K.P., T.N. Crotti, Z. Shen, M.R. Flannery, and S.R. Goldring. 2006. Identification of molecular pathways of bone-matrix dependent osteoclast gene expression insights into the mechanism of peri-implant osteolysis: ORS Transactions, Vol. 31. Chicago, IL, p. 63.Google Scholar
- Shen, Z., R. Fajardo, A. Tsay, T. Crotti, K. McHugh, S.D. Bromme, B.E. Bierbaum, and S.R. Goldring. 2004. The role of bone matrix in osteoclast differentiation and activation. J Bone Miner Res 19: S282.Google Scholar
- Taranta, A., S. Migliaccio, I. Recchia, M. Caniglia, M. Luciani, G. De Rossi, C. Dionisi-Vici, R.M. Pinto, P. Francalanci, R. Boldrini, E. Lanino, G. Dini, G. Morreale, S.H. Ralston, A. Villa, P. Vezzoni, D. Del Principe, F. Cassiani, G. Palumbo, and A. Teti. 2003. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 162: 57–68.PubMedGoogle Scholar
- Youssef, P.P., S. Triantafillou, A. Parker, M. Coleman, P.J. Roberts-Thomson, M.J. Ahern, and M.D. Smith. 1997. Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis [see comments]. J Rheumatol 24: 2291–2298.PubMedGoogle Scholar